Bioequivalence Limit, Power and interpretation [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-09-22 13:27 (127 d 02:49 ago) – Posting: # 21930
Views: 870

Dear All,

I just want basic information about Bioequivalence limit with respect to power and number of subjects.
  1. What to conclude if we got the result where study is failed in lower side i.e. below 80%...
  2. What to conclude if we got the result where study is failed in upper side i.e. above 125%...
  3. What to conclude where study's post hoc power is less then 80 or 85%?

What are the main factors associated with apart from human or instrument error?

Thanks.

Dr. Pharma88

Complete thread:

Activity
 Admin contact
21,316 posts in 4,446 threads, 1,489 registered users;
online 6 (0 registered, 6 guests [including 2 identified bots]).
Forum time: Wednesday 15:16 CET (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5